New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by

Series D raises $25mm for Zeltiq
30 Jun 2010
Executive Summary
Zeltiq (developing the first non-invasive procedure for fat reduction) raised $25mm in its Series D financing led by first-time investor Aisling Capital, which adds a board member. Returning shareholders Advanced Technology Ventures, Frazier Healthcare Ventures, and Venrock also participated.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com